美股异动丨BioNtech盘前拉升涨超3%，Q3营收大超预期

Core Insights - BioNtech SE (BNTX.US) shares rose over 3% in pre-market trading following the announcement of Q3 2025 revenue of €1.52 billion, which exceeded market expectations of €960 million, representing a year-over-year growth of 22.08% [1] Financial Performance - Q3 2025 revenue reached €1.52 billion, surpassing the market forecast of €960 million [1] - Year-over-year revenue growth was reported at 22.08% [1]